Empery Asset Management »

Satellos Bioscience shares owned by Empery Asset Management

Quarter-by-quarter ownership of Satellos Bioscience shares owned by Empery Asset Management from 13F filings

Historical chart of Empery Asset Management investment in Satellos Bioscience

Tip: Access up to 7 years of quarterly data

All positions including Satellos Bioscience held by Empery Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Satellos Bioscience by Empery Asset Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $1.3M 230k 5.63

More positions owned by Empery Asset Management

X4 Pharmaceuticals Com New (XFOR)
Empery Digital Com New (EMPD)
Precision Biosciences Com New (DTIL)
Imperial Pete Com New (IMPP)
Venu Hldg Corp (VENU)
Tenaya Therapeutics (TNYA)
Us Energy Corp Wyoming (USEG)
Scynexis Com New (SCYX)
Cyngn Inc Com Par $0 00001 (CYN)
Jaguar Uranium Corp Cl A Com Shs
Satellos Bioscience
Critical Metals Corp Pubco Ord Shs (CRML)
Ur-energy (URG)
Promis Neurosciences Com Shs (PMN)
Super League Enterprise Com New (SLE)

View all positions for Empery Asset Management

Top funds holding Satellos Bioscience

Franklin Resources
Vivo Capital
Point72 Asset Management
Woodline Partners
Sphera Funds Management
Suvretta Capital Management
Soleus Capital Management
Avidity Partners Management
Millennium Management
683 Capital Management
Empery Asset Management
ADAR1 Capital Management
Citadel Advisors
Hrt Financial
Morgan Stanley

View all funds holding Satellos Bioscience